Cullinan Management ROE Ratio 2011-2026 | CGEM

Annual ROE Ratio Cullinan Management

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-28.35	-33.76	20.79	-15.43	67.85	51.76	68.71	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
68.71	-33.76	18.8

Quarterly ROE Ratio Cullinan Management

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-40.7	-35.94	-28.11	-21.59	-29.95	-31.85	-31.89	-26.74	-30.97	-26.85	8.53	21.62	17.73	18.06	-14.45	-7.18	-12.13	-13.19	-13.94	-11.78	-11.78	-6.83	-2.5	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
21.62	-40.7	-14.45

ROE Ratio of other stocks in the Biotechnology industry

Issuer	ROE Ratio	Price	% 24h	Market Cap	Country
Acasti Pharma ACST	-14.36	-	4.01 %	$ 150 M	Canada
Adverum Biotechnologies ADVM	-185.15	-	-	$ 86.2 M	USA
MorphoSys AG MOR	15.76	-	2.43 %	$ 254 M	Germany
Ascendis Pharma A/S ASND	-43.41	$ 234.24	-0.3 %	$ 5 B	Danmark
ARCA biopharma ABIO	-21.9	-	1052.0 %	$ 415 M	USA
AgeX Therapeutics AGE	-270.67	-	-10.17 %	$ 12.2 K	USA
Aptorum Group Limited APM	-20.19	$ 0.81	1.31 %	$ 4.42 M	China
Aeglea BioTherapeutics AGLE	-21.7	-	-	$ 1.01 B	USA
Atea Pharmaceuticals AVIR	-38.37	$ 4.66	1.42 %	$ 393 M	USA
AIkido Pharma AIKI	-36.89	-	1.93 %	$ 17.4 M	USA
I-Mab IMAB	-85.31	-	-	$ 866 M	China
Axsome Therapeutics AXSM	-207.46	$ 167.61	-4.09 %	$ 8.34 B	USA
Akero Therapeutics AKRO	-33.6	-	-	$ 3.67 B	USA
Albireo Pharma ALBO	-19.38	-	-0.23 %	$ 916 M	USA
Alexion Pharmaceuticals, Inc. ALXN	5.18	-	-	$ 40.3 B	USA
Alterity Therapeutics Limited ATHE	-36.22	$ 3.33	0.79 %	$ 8.01 B	Australia
Biophytis SA BPTS	-751.94	-	-13.47 %	$ 169 M	France
Allena Pharmaceuticals ALNA	-257.91	-	3.16 %	$ 1.9 M	USA
AlloVir ALVR	-51.87	-	4.14 %	$ 49.1 M	USA
EyeGate Pharmaceuticals, Inc. EYEG	-115.61	-	-1.52 %	$ 24.7 M	USA
Ampio Pharmaceuticals AMPE	-256.9	-	-11.43 %	$ 502 K	USA
Midatech Pharma plc MTP	-330.29	-	-18.52 %	$ 27.3 M	Britain
Applied Molecular Transport AMTI	-207.64	-	-	$ 10.1 M	USA
Akouos AKUS	-37.09	-	0.23 %	$ 488 M	USA
BioVie BIVI	-92.27	$ 1.25	0.4 %	$ 1.85 M	USA
Acorda Therapeutics ACOR	160.08	-	-24.86 %	$ 820 K	USA
Acer Therapeutics ACER	156.54	-	2.71 %	$ 14 M	USA
Aravive ARAV	-716.17	-	-13.39 %	$ 1.45 M	USA
Институт стволовых клеток человека ISKJ	17.55	-	-	-	Russia
BioMarin Pharmaceutical BMRN	7.54	$ 63.02	0.15 %	$ 12 B	USA
Applied Genetic Technologies Corporation AGTC	-62.37	-	-	$ 26.5 M	USA
Alpine Immune Sciences ALPN	-32.19	-	-	$ 2.17 B	USA
CASI Pharmaceuticals CASI	-43.38	$ 0.79	4.29 %	$ 108 M	USA
Catalyst Biosciences CBIO	540.06	$ 12.71	10.81 %	$ 837 M	USA
Aeterna Zentaris AEZS	-401.79	-	5.93 %	$ 314 M	Canada
Capricor Therapeutics CAPR	-98.61	$ 27.89	0.07 %	$ 747 M	USA
Aptose Biosciences APTO	559.76	-	-45.71 %	$ 1.2 M	Canada
Aptinyx APTX	-169.38	-	-39.0 %	$ 4.57 M	USA
Avenue Therapeutics ATXI	-418.16	-	-52.27 %	$ 4.45 M	USA
Aridis Pharmaceuticals ARDS	125.33	-	17.91 %	$ 11.1 M	USA
BioNTech SE BNTX	1.11	$ 110.88	0.86 %	$ 27.2 B	Germany
Amneal Pharmaceuticals AMRX	67.61	$ 14.72	2.08 %	$ 4.55 B	USA
Arena Pharmaceuticals ARNA	-91.56	-	-6.81 %	$ 3.04 B	USA
Certara CERT	-1.14	$ 6.67	2.77 %	$ 1.07 B	USA
CureVac N.V. CVAC	-59.8	-	-	$ 867 M	Germany
Athira Pharma ATHA	-216.19	-	-	$ 269 M	USA
Burford Capital Limited BUR	10.1	$ 9.32	1.25 %	$ 1.5 B	Britain
Athersys ATHX	-531.22	-	3.77 %	$ 22.4 M	USA
Autolus Therapeutics plc AUTL	-51.64	$ 1.85	6.65 %	$ 472 M	Britain